Chrome Extension
WeChat Mini Program
Use on ChatGLM

Supplementary Tables 1 - 7 from Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib ± Onartuzumab in Advanced Non–Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit

openalex(2023)

Cited 0|Views2
Key words
Biomarker Analysis,Tumor Heterogeneity,EGFR Mutations,Cancer Imaging,Non-Small Cell Lung Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined